1. Home
  2. CRL
  3. CRL News

Latest Charles River Laboratories International Inc. (CRL) News on July 12, 2025

3 Reasons to Sell CRL and 1 Stock to Buy Instead
CRL

StockStory

24 days ago

3 Reasons to Sell CRL and 1 Stock to Buy Instead

3 Unpopular Stocks in Hot Water
CRL

StockStory

25 days ago

3 Unpopular Stocks in Hot Water

Drug Development Inputs & Services Stocks Q1 Recap: Benchmarking Fortrea (NASDAQ:FTRE)
CRL

StockStory

25 days ago

Drug Development Inputs & Services Stocks Q1 Recap: Benchmarking Fortrea (NASDAQ:FTRE)

Drug Development Inputs & Services Stocks Q1 Highlights: IQVIA (NYSE:IQV)
CRL

StockStory

25 days ago

Drug Development Inputs & Services Stocks Q1 Highlights: IQVIA (NYSE:IQV)

Charles River Announces Endosafe® Cartridge Recycling Program, Strengthening Sustainability Commitment
CRL

Business Wire

a month ago

Charles River Announces Endosafe® Cartridge Recycling Program, Strengthening Sustainability Commitment

CRL

Argus Research

a month ago

Analyst Report: Charles River Laboratories Int

CRL

Argus Research

a month ago

Market Update: BJ, CRL, PRGO, SPH

CRL Q1 Earnings Call: Regulatory Changes and Market Stabilization Shape Outlook
CRL

StockStory

a month ago

CRL Q1 Earnings Call: Regulatory Changes and Market Stabilization Shape Outlook

Why Is Charles River (CRL) Down 0.1% Since Last Earnings Report?
CRL

Zacks

a month ago

Why Is Charles River (CRL) Down 0.1% Since Last Earnings Report?

1 Safe-and-Steady Stock Worth Your Attention and 2 to Steer Clear Of
CRL

StockStory

a month ago

1 Safe-and-Steady Stock Worth Your Attention and 2 to Steer Clear Of

Drug Development Inputs & Services Stocks Q1 In Review: Repligen (NASDAQ:RGEN) Vs Peers
CRL

StockStory

a month ago

Drug Development Inputs & Services Stocks Q1 In Review: Repligen (NASDAQ:RGEN) Vs Peers

Drug Development Inputs & Services Q1 Earnings: UFP Technologies (NASDAQ:UFPT) Simply the Best
CRL

StockStory

a month ago

Drug Development Inputs & Services Q1 Earnings: UFP Technologies (NASDAQ:UFPT) Simply the Best

Charles River Stock May Gain From Extended CHDI Research Deal on HD
CRL

Zacks

a month ago

Charles River Stock May Gain From Extended CHDI Research Deal on HD

Charles River Laboratories to Present at William Blair and Jefferies Conferences
CRL

Business Wire

a month ago

Charles River Laboratories to Present at William Blair and Jefferies Conferences

1 Value Stock with Impressive Fundamentals and 2 to Steer Clear Of
CRL

StockStory

a month ago

1 Value Stock with Impressive Fundamentals and 2 to Steer Clear Of

Charles River Laboratories International, Inc. (CRL): A Bull Case Theory
CRL

Insider Monkey

a month ago

Charles River Laboratories International, Inc. (CRL): A Bull Case Theory

CRL

MT Newswires

a month ago

Charles River Laboratories, CHDI Foundation Extend Collaboration

Charles River and CHDI Foundation Extend Multi-Decade Collaboration on Huntington’s Disease Research
CRL

Business Wire

a month ago

Charles River and CHDI Foundation Extend Multi-Decade Collaboration on Huntington’s Disease Research

Redburn Upgrades Charles River Laboratories (CRL) to Buy, Cuts PT
CRL

Insider Monkey

2 months ago

Redburn Upgrades Charles River Laboratories (CRL) to Buy, Cuts PT

CRL

MT Newswires

2 months ago

Redburn Atlantic Upgrades Charles River Laboratories International to Buy From Neutral, Adjusts Price Target to $182 From $188

Guardant Health, Evolent Health, Charles River Laboratories, Avantor, and Lumen Stocks Trade Down, What You Need To Know
CRL

StockStory

2 months ago

Guardant Health, Evolent Health, Charles River Laboratories, Avantor, and Lumen Stocks Trade Down, What You Need To Know

Should You Continue to Hold Charles River Stock in Your Portfolio?
CRL

Zacks

2 months ago

Should You Continue to Hold Charles River Stock in Your Portfolio?

Drug Development Inputs & Services Stocks Q1 Results: Benchmarking Charles River Laboratories (NYSE:CRL)
CRL

StockStory

2 months ago

Drug Development Inputs & Services Stocks Q1 Results: Benchmarking Charles River Laboratories (NYSE:CRL)

CRL

MT Newswires

2 months ago

TD Cowen Upgrades Charles River Laboratories International to Buy From Hold, Adjusts PT to $179 From $105

Understanding Charles River (CRL) Reliance on International Revenue
CRL

Zacks

2 months ago

Understanding Charles River (CRL) Reliance on International Revenue

Charles River Laboratories to Present at Bank of America Health Care Conference
CRL

Business Wire

2 months ago

Charles River Laboratories to Present at Bank of America Health Care Conference

Earnings To Watch: Fortrea (FTRE) Reports Q1 Results Tomorrow
CRL

StockStory

2 months ago

Earnings To Watch: Fortrea (FTRE) Reports Q1 Results Tomorrow

CRL

MT Newswires

2 months ago

Morgan Stanley Cuts Price Target on Charles River Laboratories International to $168 From $184

Eli Lilly extends Purdue alliance; EMA investigates Valneva shot
CRL

BioPharma Dive

2 months ago

Eli Lilly extends Purdue alliance; EMA investigates Valneva shot

CRL

MT Newswires

2 months ago

Barclays Adjusts Price Target on Charles River Laboratories International to $155 From $145, Maintains Equalweight Rating

CRL

MT Newswires

2 months ago

Deutsche Bank Adjusts Price Target on Charles River Laboratories International to $180 From $140, Maintains Buy Rating

CRL

MT Newswires

2 months ago

UBS Cuts Price Target on Charles River Laboratories International to $150 From $185, Keeps Neutral Rating

CRL

MT Newswires

2 months ago

Jefferies Adjusts Price Target on Charles River Laboratories International to $142 From $100, Maintains Hold Rating

CRL

MT Newswires

2 months ago

JPMorgan Adjusts Price Target on Charles River Laboratories International to $145 From $165, Maintains Neutral Rating

CRL

MT Newswires

2 months ago

Citigroup Adjusts Price Target on Charles River Laboratories International to $150 From $175, Maintains Neutral Rating

What Is Charles River Laboratories International, Inc.'s (NYSE:CRL) Share Price Doing?
CRL

Simply Wall St.

2 months ago

What Is Charles River Laboratories International, Inc.'s (NYSE:CRL) Share Price Doing?

CRL

MT Newswires

2 months ago

Deutsche Bank Adjusts Charles River Laboratories International Price Target to $180 From $140, Maintains Buy Rating

CRL

MT Newswires

2 months ago

Charles River Laboratories Q1 Non-GAAP Earnings Rise, Revenue Falls

Charles River Laboratories’s (NYSE:CRL) Q1: Strong Sales, Stock Jumps 22.4%
CRL

StockStory

2 months ago

Charles River Laboratories’s (NYSE:CRL) Q1: Strong Sales, Stock Jumps 22.4%

Charles River Laboratories (CRL) Beats Q1 Earnings and Revenue Estimates
CRL

Zacks

2 months ago

Charles River Laboratories (CRL) Beats Q1 Earnings and Revenue Estimates

CRL

Associated Press Finance

2 months ago

Charles River: Q1 Earnings Snapshot

Charles River Laboratories Announces First-Quarter 2025 Results
CRL

Business Wire

2 months ago

Charles River Laboratories Announces First-Quarter 2025 Results

Charles River Laboratories Announces Governance Updates and Strategic Review to Enhance Long-Term Stockholder Value
CRL

Business Wire

2 months ago

Charles River Laboratories Announces Governance Updates and Strategic Review to Enhance Long-Term Stockholder Value

Charles River Laboratories (CRL) To Report Earnings Tomorrow: Here Is What To Expect
CRL

StockStory

2 months ago

Charles River Laboratories (CRL) To Report Earnings Tomorrow: Here Is What To Expect

CRL

Morningstar Research

2 months ago

Analyst Report: Charles River Laboratories International, Inc.

Progyny (PGNY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
CRL

Zacks

2 months ago

Progyny (PGNY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Charles River Laboratories International, Inc. (CRL): Among the Worst Performing Stocks in S&P 500 So Far in 2025
CRL

Insider Monkey

2 months ago

Charles River Laboratories International, Inc. (CRL): Among the Worst Performing Stocks in S&P 500 So Far in 2025

Analysts Estimate Charles River Laboratories (CRL) to Report a Decline in Earnings: What to Look Out for
CRL

Zacks

2 months ago

Analysts Estimate Charles River Laboratories (CRL) to Report a Decline in Earnings: What to Look Out for

Charles River Announces Inaugural Advanced Therapy Incubator Program Cohort
CRL

Business Wire

2 months ago

Charles River Announces Inaugural Advanced Therapy Incubator Program Cohort

Here's How Charles River is Placed Just Ahead of Q1 Earnings
CRL

Zacks

2 months ago

Here's How Charles River is Placed Just Ahead of Q1 Earnings

3 Cash-Producing Stocks That Concern Us
CRL

StockStory

3 months ago

3 Cash-Producing Stocks That Concern Us

Upslope Capital Management Sold Charles River (CRL) Due to Thesis Break
CRL

Insider Monkey

3 months ago

Upslope Capital Management Sold Charles River (CRL) Due to Thesis Break

Charles River Leverages Advanced Technology to Expedite Oncology Drug Discovery and Development
CRL

Business Wire

3 months ago

Charles River Leverages Advanced Technology to Expedite Oncology Drug Discovery and Development

CRL

MT Newswires

3 months ago

Jefferies Adjusts Price Target on Charles River Laboratories International to $100 From $169, Maintains Hold Rating

Charles River Laboratories International, Inc. (CRL): Among Mid-Cap Stocks Insiders Were Buying in Q1 2025
CRL

Insider Monkey

3 months ago

Charles River Laboratories International, Inc. (CRL): Among Mid-Cap Stocks Insiders Were Buying in Q1 2025

CRL

MT Newswires

3 months ago

Baird Adjusts Price Target on Charles River Laboratories International to $118 From $101, Keeps Neutral Rating

Charles River Laboratories Schedules First-Quarter 2025 Earnings Release and Conference Call
CRL

Business Wire

3 months ago

Charles River Laboratories Schedules First-Quarter 2025 Earnings Release and Conference Call

Strength Seen in Charles River (CRL): Can Its 6.9% Jump Turn into More Strength?
CRL

Zacks

3 months ago

Strength Seen in Charles River (CRL): Can Its 6.9% Jump Turn into More Strength?

CRL

MT Newswires

3 months ago

TD Cowen Adjusts Charles River Laboratories International's PT to $105 From $179, Keeps Hold Rating

CRL

MT Newswires

3 months ago

BofA Securities Cuts Charles River Laboratories International Price Target to $150 From $185

CRL

MT Newswires

3 months ago

Baird Adjusts PT on Charles River Laboratories International to $101 From $155, Keeps Neutral Rating

CRL

MT Newswires

3 months ago

Deutsche Bank Adjusts Price Target on Charles River Laboratories International to $140 From $210

Why Charles River Laboratories International, Inc. (CRL) Went Down On Thursday?
CRL

Insider Monkey

3 months ago

Why Charles River Laboratories International, Inc. (CRL) Went Down On Thursday?

CRL

Morningstar Research

3 months ago

Analyst Report: Charles River Laboratories International, Inc.

CRL

MT Newswires

3 months ago

Barclays Adjusts Price Target on Charles River Laboratories International to $145 From $160

Will Charles River (CRL) Beat Estimates Again in Its Next Earnings Report?
CRL

Zacks

3 months ago

Will Charles River (CRL) Beat Estimates Again in Its Next Earnings Report?

Bausch + Lomb (BLCO) Moves 13.9% Higher: Will This Strength Last?
CRL

Zacks

3 months ago

Bausch + Lomb (BLCO) Moves 13.9% Higher: Will This Strength Last?

CRL

MT Newswires

3 months ago

Evercore ISI Adjusts PT on Charles River Laboratories International to $135 From $175, Maintains In Line Rating

CRL

MT Newswires

3 months ago

Goldman Sachs Adjusts Charles River Laboratories International PT to $150 From $170, Maintains Neutral Rating

CRL

Morningstar Research

3 months ago

Analyst Report: Charles River Laboratories International, Inc.

CRL

MT Newswires

3 months ago

Baird Adjusts Charles River Laboratories International Price Target to $155 From $173, Maintains Neutral Rating

Charles River & Valo Health's Logica Identifies New Lupus Drug Candidate
CRL

Zacks

3 months ago

Charles River & Valo Health's Logica Identifies New Lupus Drug Candidate

CRL

MT Newswires

4 months ago

Charles River, Valo Health Identify First Lupus Treatment Candidate Using Logica AI Platform

Charles River and Valo Health Identify a Potential Therapeutic for Lupus Using Logica®, an AI-Powered Drug Discovery Platform
CRL

Business Wire

4 months ago

Charles River and Valo Health Identify a Potential Therapeutic for Lupus Using Logica®, an AI-Powered Drug Discovery Platform

Why Charles River Laboratories International, Inc. (CRL) is Among the Best Diagnostics Stocks to Invest in Right Now
CRL

Insider Monkey

4 months ago

Why Charles River Laboratories International, Inc. (CRL) is Among the Best Diagnostics Stocks to Invest in Right Now

Charles River (CRL) Up 1.9% Since Last Earnings Report: Can It Continue?
CRL

Zacks

4 months ago

Charles River (CRL) Up 1.9% Since Last Earnings Report: Can It Continue?

CRL

MT Newswires

4 months ago

Goldman Sachs Downgrades Charles River Laboratories International to Neutral From Buy, Adjusts Price Target to $170 From $190

Drug Development Inputs & Services Stocks Q4 In Review: Medpace (NASDAQ:MEDP) Vs Peers
CRL

StockStory

4 months ago

Drug Development Inputs & Services Stocks Q4 In Review: Medpace (NASDAQ:MEDP) Vs Peers

CRL

Argus Research

4 months ago

Analyst Report: Charles River Laboratories Int

CRL

Argus Research

4 months ago

Market Digest: CRL, DOCU

3 Reasons CRL is Risky and 1 Stock to Buy Instead
CRL

StockStory

4 months ago

3 Reasons CRL is Risky and 1 Stock to Buy Instead

Is Charles River Laboratories International, Inc.'s (NYSE:CRL) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
CRL

Simply Wall St.

4 months ago

Is Charles River Laboratories International, Inc.'s (NYSE:CRL) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Charles River Laboratories to Present at Barclays Global Healthcare Conference
CRL

Business Wire

4 months ago

Charles River Laboratories to Present at Barclays Global Healthcare Conference

Spotting Winners: Charles River Laboratories (NYSE:CRL) And Drug Development Inputs & Services Stocks In Q4
CRL

StockStory

4 months ago

Spotting Winners: Charles River Laboratories (NYSE:CRL) And Drug Development Inputs & Services Stocks In Q4

CRL

MT Newswires

4 months ago

Charles River Laboratories Shares Rise After Citigroup Upgrade

CRL

MT Newswires

4 months ago

Citigroup Upgrades Charles River Laboratories International to Neutral From Sell, Adjusts Price Target to $175 From $155

CRL

MT Newswires

4 months ago

Redburn Atlantic Upgrades Charles River Laboratories International to Neutral From Sell, Adjusts PT to $188 From $171

Bell Global Equities Sold Charles River Laboratories International (CRL) Due To Its Potential For On-going Risk To Earnings
CRL

Insider Monkey

4 months ago

Bell Global Equities Sold Charles River Laboratories International (CRL) Due To Its Potential For On-going Risk To Earnings

Charles River Laboratories International's (NYSE:CRL) Soft Earnings Don't Show The Whole Picture
CRL

Simply Wall St.

5 months ago

Charles River Laboratories International's (NYSE:CRL) Soft Earnings Don't Show The Whole Picture

SGH and Charles River team up for CGMP cell banking services
CRL

Hospital Management

5 months ago

SGH and Charles River team up for CGMP cell banking services

Charles River Announces Agreement with Singapore General Hospital
CRL

Business Wire

5 months ago

Charles River Announces Agreement with Singapore General Hospital

Deciphering Charles River (CRL) International Revenue Trends
CRL

Zacks

5 months ago

Deciphering Charles River (CRL) International Revenue Trends

UFP Technologies (UFPT) Reports Q4: Everything You Need To Know Ahead Of Earnings
CRL

StockStory

5 months ago

UFP Technologies (UFPT) Reports Q4: Everything You Need To Know Ahead Of Earnings

CRL

MT Newswires

5 months ago

TD Cowen Adjusts Price Target on Charles River Laboratories International to $179 From $182, Keeps Hold Rating

CRL

Argus Research

5 months ago

Daily – Vickers Top Buyers & Sellers for 02/24/2025

Charles River Laboratories International Full Year 2024 Earnings: EPS Misses Expectations
CRL

Simply Wall St.

5 months ago

Charles River Laboratories International Full Year 2024 Earnings: EPS Misses Expectations

CRL

MT Newswires

5 months ago

Stephens Cuts Charles River Laboratories International Price Target to $190 From $240

CRL

MT Newswires

5 months ago

Deutsche Bank Adjusts Charles River Laboratories International Price Target to $210 From $215, Maintains Buy Rating

CRL

MT Newswires

5 months ago

JPMorgan Adjusts Price Target on Charles River Laboratories International to $165 From $175, Maintains Neutral Rating

CRL

MT Newswires

5 months ago

Baird Adjusts Price Target on Charles River Laboratories International to $173 From $177, Maintains Neutral Rating

Share on Social Networks: